Literature DB >> 1777365

N-acetylation phenotyping using dapsone in a Jordanian population.

Y M Irshaid1, H F al-Hadidi, M A Abuirjeie, N M Rawashdeh.   

Abstract

1. The N-acetylation of dapsone (DDS) was studied in 160 unrelated healthy Jordanian volunteers. 2. The frequency of slow acetylators determined using the plasma monoacetyldapsone (MADDS) to DDS ratio (MADDS/DDS), was 67.5% with a 95% confidence interval of 59 to 76%. Slow acetylators had an acetylation ratio of less than 0.42. 3. Applying the Hardy-Weinberg Law, the frequency of the recessive allele controlling slow acetylation was found to be 0.82 +/- 0.02. 4. The frequency distribution histogram of the plasma MADDS/DDS ratio showed an apparent trimodal pattern. The number of homozygous (n = 16) and heterozygous (n = 36) rapid acetylators derived from the observed data did not agree with those predicted for the respective rapid acetylators (n = 5 and n = 47) according to the Hardy-Weinberg Law. The suggested antimode used to discriminate the two groups was 0.82. 5. The mean plasma concentration of MADDS and the mean plasma acetylation ratio were about three times lower in slow than in rapid acetylators. However, there was no difference in mean plasma DDS concentration between slow and rapid acetylators. 6. There was a significant correlation (r = 0.853, P less than 0.001) between plasma MADDS concentration and the acetylation ratio. For DDS such a correlation was absent (r = 0.059, P = 0.23).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777365      PMCID: PMC1368520          DOI: 10.1111/j.1365-2125.1991.tb03901.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  25 in total

1.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

2.  Acetylation phenotypes in patients with bladder carcinoma.

Authors:  M P Bicho; L Breitenfeld; A A Carvalho; C F Manso
Journal:  Ann Genet       Date:  1988

3.  Interindividual and intraindividual variability in acetylation: characterization with caffeine.

Authors:  B G Hardy; C Lemieux; S E Walker; W R Bartle
Journal:  Clin Pharmacol Ther       Date:  1988-08       Impact factor: 6.875

4.  The frequency of isoniazid acetylase enzyme deficiency among Egyptians.

Authors:  N Hashem; S Khalifa; A Nour
Journal:  Am J Phys Anthropol       Date:  1969-07       Impact factor: 2.868

Review 5.  N-acetylation pharmacogenetics.

Authors:  W W Weber; D W Hein
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

6.  Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test.

Authors:  A el-Yazigi; K Chaleby; C R Martin
Journal:  J Clin Pharmacol       Date:  1989-03       Impact factor: 3.126

7.  Acetylator phenotype and congenital malformations.

Authors:  C Stoll; M P Roth; B Dott; N Doumit; Y Alembik; M Welsch; J L Imbs
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 8.  Acetylator genotype and arylamine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Biochim Biophys Acta       Date:  1988-08-03

9.  N-acetylator phenotypes in hyperthyroidism.

Authors:  W Siegmund; G Franke; S Meng; P Gothe; W Meng
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1988-08

10.  Acetylator polymorphism in discoid lupus erythematosus.

Authors:  J M Ladero; L C Jiménez; M J Fernández; A Robledo
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

View more
  6 in total

1.  Is there any difference between acetylator phenotypes in tuberculosis patients and healthy subjects?

Authors:  Hossein Khalili; Simin Dashti-Khavidaki; Mohsen Amini; Reza Mahjub; Mahboobeh Hajiabdolbaghi
Journal:  Eur J Clin Pharmacol       Date:  2010-03       Impact factor: 2.953

2.  Effect of acetaminophen on sulfamethazine acetylation in male volunteers.

Authors:  I M Tahir; T Iqbal; S Saleem; H Mehboob; N Akhter; M Riaz
Journal:  Int J Immunopathol Pharmacol       Date:  2015-10-30       Impact factor: 3.219

Review 3.  Drug acetylation in liver disease.

Authors:  M Levy; Y Caraco; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

4.  Acetylator phenotypes of Jordanian diabetics.

Authors:  Y Irshaid; H al-Hadidi; M Abuirjeie; A Latif; O Sartawi; N Rawashdeh
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.

Authors:  Yazun Bashir Jarrar; Ayat Ahmed Balasmeh; Wassan Jarrar
Journal:  Libyan J Med       Date:  2018-12       Impact factor: 1.657

6.  Isoniazid acetylation phenotypes in the Sudanese population; findings and implications.

Authors:  Monadil H Ali; Alian A Alrasheedy; Dan Kibuule; Mohamed Azmi Hassali; Brian Godman; Mohammed F Abdelwahab; Raef Y Abbadi
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.